Novo Holdings invests in Biocomposites, joining TA Associates to support the medical device company's global expansion and innovation.

League and Arcadia announce partnership to combine CX platform and healthcare data to improve personalized health recommendations.

Trinity Capital appoints John Orlando as Managing Director of Life Sciences in Boston, expanding its presence in the Northeast region.

Clearlake Capital makes majority investment in ModMed, a healthcare SaaS platform, to drive growth and innovation in specialty-specific technology.

Centinel Spine secures $60M loan from SLR Capital Partners, with option for additional $10M, to refinance debt and fund growth.

Stellus Capital Management provides unitranche financing for Northlane Capital Partners' investment in Plus Delta Partners, a fundraising training provider.

Deerfield Management partners with Qatar Investment Authority to boost healthcare innovation and startup ecosystem in Qatar and MENA region.

Prickly Pear Health, an AI-powered digital health platform for menopausal brain health, secures pre-seed funding from Bayless Ventures and AZ-VC.

Trinity Capital commits $15M to Cagent Vascular, augmenting $45M equity financing for innovative vascular treatment technologies.

NaviFUS Corp. revolutionizes brain disorder treatments using ultrasound and Taiwan's advanced chip technology for drug delivery and neuromodulation.

SteelSky Ventures invests in Posterity Health, a tech-driven platform focused on male fertility care, to improve outcomes and reduce costs.

Company Ventures launches Terrarium, a venture studio for healthcare tech startups, partnering with Cactus and Wellstar Health System.

NEC's venture fund invests in Aetion, aiming to commercialize Japanese health data for global drug development using real-world evidence.

Stellus Capital Management provides senior debt financing and equity co-investment for ICV Partners' investment in Environmental Remedies, LLC.

Mesirow hires John Calcagnini as Managing Director to expand healthcare coverage in its Investment Banking group.

Endovascular Engineering secures $42M in Series B funding to advance its clot removal technology for pulmonary embolism treatment.

Perceive Pharma secures $15M in Series A funding to develop novel neuroprotective therapies for glaucoma and other ophthalmic diseases.

HealthEdge Investment Partners completes sale of LifeSync, a patient monitoring device manufacturer, to Amphenol for strong returns.

Cyrano Therapeutics grants KYORIN option to license CYR-064 for post-viral smell loss treatment in Japan, with potential milestone payments.

Atria Health partners with cardiologists to build independent practices, providing capital and expertise to help them thrive in value-based care.